Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample
- 18 August 2022
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 37 (5) , 507-511
Abstract
Per the American Society for Apheresis, therapeutic plasma exchange (TPE) is a Category III indication in the management of immune thrombocytopenia (ITP). This nationally representative study evaluates TPE utilization in hospitalized adults with a primary admission diagnosis of ITP. Hospitalizations with ITP as the primary admitting diagnosis were analyzed from the 2010 to 2014 National Inpatient Sample, the largest all‐payer inpatient database in the United States. Univariate and multivariable logistic regressions were used to determine clinical outcomes in ITP patients undergoing TPE. Sampling weights were applied to generate nationally representative estimates. From 2010 to 2014, there were a total of 56,149 admissions with a primary admitting diagnosis of ITP, of which 0.66% admissions (n = 372) also coded TPE. Most subjects undergoing TPE were the highest disease severity class: major (34.6%) and extreme severity (31.0%), by all‐patients refined diagnoses‐related groups severity of illness subclass. After multivariable analysis, underlying severity of illness remained the most significant predictor of TPE (P < .001). ITP admissions with TPE had a high rate of comorbidities (50%) and significantly longer mean length of hospital stay than those without (P < .001). TPE was reported in ~0.6% of hospitalizations with ITP as the primary diagnosis in this nationally representative sample from 2010 to 2014. TPE was performed in patients with the highest severity of underlying illness, and higher rates of comorbidities.Keywords
This publication has 16 references indexed in Scilit:
- Platelet transfusion practices in immune thrombocytopenia related hospitalizationsTransfusion, 2018
- Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortalityBlood, 2015
- One size will never fit all: the future of research in pediatric transfusion medicinePediatric Research, 2014
- Firearm-Related Injuries Affecting the Pediatric PopulationPediatrics, 2012
- The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsAmerican Journal of Hematology, 2010
- Immune Thrombocytopenic PurpuraNew England Journal of Medicine, 2002
- The Canadian Experience Using Plasma Exchange for Immune Thrombocytopenic PurpuraTransfusion Science, 1998
- Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpuraTransfusion, 1984
- Plasma Exchange in Autoimmune Thrombocytopenic PurpuraVox Sanguinis, 1983
- One‐Year Follow‐Up of Plasma Exchange Therapy in 14 Patients with Idiopathic Thrombocytopenic PurpuraTransfusion, 1981